James A. McNulty - 16 Mar 2024 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
CHIEF FINANCIAL OFFICER, 10%+ Owner
Signature
/s/ James A. McNulty
Issuer symbol
INTI
Transactions as of
16 Mar 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 13:34:37 UTC
Previous filing
17 May 2023
Next filing
23 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTI Stock Option Award $0 +100,000 $0.000000 100,000 16 Mar 2024 Common Stock 100,000 $0.0800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock options were issued to the Reporting Person on March 16, 2024 pursuant to the Issuer's 2014 Equity Incentive Plan. The common stock options vested immediately.